Use of antipsychotics in older home care patients in Finland

Drugs and Aging

Volumn 25, Issue 4, 2008, Pages 335-342

  Alanen, Hanna Mari ^a   Finne Soveri, Harriet ^b   Noro, Anja ^b   Leinonen, Esa ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antipsychotics, therapeutic use; Elderly

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; HYPNOTIC AGENT; LEVOMEPROMAZINE; LITHIUM; MELPERONE; NEUROLEPTIC AGENT; OLANZAPINE; PERICIAZINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; ZUCLOPENTHIXOL;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG USE; ELDERLY CARE; FEMALE; FINLAND; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PARKINSONISM; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL;

EID: 41149181180     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825040-00006     Document Type: Article

References (25)

1. Alexopoulos GS, Streim J, Carpenter D, et al. Expert consensus panel for using antipsychotic drugs in older patients. J Clin Psychiatry 2004; 65 Suppl. 2: 5-99; discussion 100-2; quiz 103-4
2. Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900-6
3. Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int Geriatr Psychiatry 2002; 17: 874-83
4. Hartikainen S, Rahkonen T, Kautiainen H, et al. Use of psychotropics among home-dwelling nondemented and demented elderly. Int J Geriatr Psychiatry 2003; 18: 1135-41
5. STAKES (National Research and Development Centre for Welfare and Health). Statistical summary 13/2004 [online]. Available from URL: www.stakes.info/2/ 10A/index.asp. [Accessed 2006 Nov 30]
6. Landi F, Onder G, Cesari M, et al. Comorbidity and social factors predicted hospitalization in frail elderly patients. J Clin Epidemiol 2004; 57: 832-6
7. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54 Suppl. 5: S4-9
8. Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8 Suppl. 3: 497-500
9. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000; 8: 29-34
10. Ritchie K, Artero S, Beluche I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 2004; 184: 147-52
11. Henderson AS, Korten AE, Levings C, et al. Psychotic symptoms in the elderly: a prospective study in a population sample. Int J Geriatr Psychiatry 1998; 13: 484-92
12. Forsell Y, Henderson AS. Epidemiology of paranoid symptoms in an elderly population. Br J Psychiatry 1998; 172: 429-32
13. Targum SD, Abbott JL. Psychoses in the elderly: a spectrum of disorders. J Clin Psychiatry 1999; 60 Suppl. 8: 4-10
14. Morris JN, Brant E, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. Am Geriatr Soc 1997; 45: 1017-24
15. Kwan CW, Chi I, Lam TP, et al. Validation of the Minimum Data Set for Home Care Assessment Instrument for Hong Kong Chinese Elders. Clin Gerontol 2000; 21 (14): 35-48
16. Landi F, Tua E, Onder G, et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000; 38: 1184-90
17. Schatzberg AF, Nemeroff CB. Essentials of clinical psychopharmacology. Washington, DC: American Psychiatry Publishing, 2005
18. Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999; 54 (11): M546-53
19. Morris JN, Fries BE, Mehr DR, et al. MDS Cognitive Performance Scale. J Gerontol 1994; 49: M174-82
20. Snowdon J, Day S, Baker W. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 2005; 20: 1146-52
21. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-41
22. Aarsland D, Larsen JP, Cummings JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999; 56: 595-601
23. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000; 123 (Pt 4): 733-45
24. Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 2006; 14: 6-20
25. Hartikainen S, Rahkonen T, Kautiainen H, et al. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol 2003; 18: 163-7